Caliway Biopharmaceuticals Co (TPE:6919) Interest Expense : NT$-0.42 Mil (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Caliway Biopharmaceuticals Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Caliway Biopharmaceuticals Co's interest expense for the six months ended in Jun. 2024 was NT$ -0.19 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-0.42 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Caliway Biopharmaceuticals Co's Operating Income for the six months ended in Jun. 2024 was NT$ -435.50 Mil. Caliway Biopharmaceuticals Co's Interest Expense for the six months ended in Jun. 2024 was NT$ -0.19 Mil. Caliway Biopharmaceuticals Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Caliway Biopharmaceuticals Co Interest Expense Historical Data

The historical data trend for Caliway Biopharmaceuticals Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliway Biopharmaceuticals Co Interest Expense Chart

Caliway Biopharmaceuticals Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

-3.69

-4.51

-2.90

-0.67

-0.50

Caliway Biopharmaceuticals Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Interest Expense	Get a 7-Day Free Trial				-0.36	-0.31	-0.27	-0.23	-0.19

Caliway Biopharmaceuticals Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.42 Mil.

Caliway Biopharmaceuticals Co (TPE:6919) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Caliway Biopharmaceuticals Co's Interest Expense for the six months ended in Jun. 2024 was NT$-0.19 Mil. Its Operating Income for the six months ended in Jun. 2024 was NT$-435.50 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was NT$7.46 Mil.

Caliway Biopharmaceuticals Co's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Caliway Biopharmaceuticals Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Caliway Biopharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Caliway Biopharmaceuticals Co Ltd (TPE:6919) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.99, Sec. 1, Xintai 5th Road, 32rd Floor-9, Xizhi District, New Taipei City, TWN, 221

Website

https://www.caliway.com.tw

Caliway Biopharmaceuticals Co Ltd is specialized in the development of new drugs for medical aesthetic and inflammatory diseases. Its pipeline candidate is, CBL-514, CBA-539, and CBO-012.

Caliway Biopharmaceuticals Co Headlines

No Headlines